Central America Archives - Cardiac Biotech (CBSC)

CBSC announces $375,000 Noventis Medical purchase order and new recurring revenue program for MyCardia AT cardiac monitoring devices.

Sep 11

Cardiac Biotech

CBSC Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical

CBSC secures $375K purchase order with Noventis Medical and launches recurring revenue program for MyCardia AT devices.

News

0 Comments

How can we help you?

© 2020-2026. Cardiac Biotech Solutions, Inc. - All rights reserved. | Designer